Sandra Poudrier

Co-Founder, Chief Operations Officer at RosVivo Therapeutics

Sandra has 25 experience in biotech in all aspects of product lifecycles from basic research to scale up, cGMP manufacturing, product validation, and post marketing product support. She has a patent for a diagnostic assay for pancreatitis. Sandra was also an original member of Dr. Ro’s research team which discovered the regulatory role miRNA’s have on gut motility, diabetes and obesity. Prior to working with Dr. Ro, Sandra was the Director of Quality for two divisions of a multi-national company and was responsible for the development, oversight, and execution of their international regulatory and quality systems for multinational customers such as ExxonMobil, Chevron Corporation and KOGAS.